Loom Solar has introduced the Fusion 103H three-phase 10 kW/48 V hybrid inverter that combines the functions of a solar inverter and a battery inverter in a single device. The wall-mounted inverter is ...

Prime Minister Narendra Modi on Wednesday inaugurated Phase 2B of the Mumbai Metro Line-3, stretching from Acharya Atre Chowk to Cuffe Parade. The project has been constructed at a cost of Rs 12,200 ...

Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...

Tulisokibart, an investigational anti-TL1A monoclonal antibody currently in Phase 3 trials for ulcerative colitis and Crohn’s disease, to be studied in hidradenitis suppurativa, radiographic axial ...

Use cases are emerging for induction charging, ambient IoT and midrange power transmission, and laser power beaming.

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

The MCU’s Phase 4 released instalments during 2021 and ’22, Phase 5 released during 2023, ’24, and ’25, and Phase 6 will run until 2027. Following this pattern, the MCU’s Phase 7 will likely span ...

MoonLake Immunotherapeutics (MLTX) shares plunged after the company reported results from its Phase 3 trials for sonelokimab in hidradenitis suppurativa. The VELA-2 study missed its main goal, ...

NEW DELHI: A top executive of homegrown telecom gear maker HFCL said it has won deals in 40-45% gram panchayats (GPs) under the BharatNet Phase 3 programme, and has started supplying its network ...

Prime Minister Narendra Modi on Wednesday (October 8, 2025) inaugurated the final phase of Mumbai’s first fully underground Metro 3, making 33.5-km Aqua Line operational, which will connect Aarey in ...

ZUG, Switzerland - MoonLake Immunotherapeutics (NASDAQ:MLTX), a $3.94 billion market cap biotech company trading near its 52-week high of $62.75, announced Sunday that its Phase 3 VELA program testing ...